Stage 4 Liver CancerNCT01549522
Qualitative Research for Stage 4 Liver Cancer Patients and Their Caregivers
An observational study of Stage 4 Liver Cancer, run by Find A Cure Panel at 1 site in United States.
Trial summary
This is opinion based, experiential research and is NOT a drug trial. Read more about this study
- Who is it for?
- Ages 22 years and older
- Conditions the study is for
- Stage 4 Liver Cancer
- What is being tested?
- bulletin board or telephone depth interview (TDI) and interview regarding experiences and opinions as to condition and treatment
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 30 participants
- Where
- 1 siteUnited States
- Study dates
- Mar 2012to Apr 2012
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 22 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: liver cancer stage 4 patients and caregivers
Who may be able to join
- stage 4 liver cancer patients and caregivers
Who cannot join
- loved ones passed away
Trial locations and contacts
1 site in 1 country.
United States1 site, 1 recruiting
- Recruiting
National
Los Angeles, California, 90021
douglas lowell, 323-717-8117, info@findacurepanel.com
douglas lowell
About this study
Official title: Phase 1 0 Qualitative Research for Stage 4 Liver Cancer Patients and Their Caregivers.
This is opinion based, experiential research and is NOT a drug trial.
- Conditions
- Stage 4 Liver Cancer
- Being tested
- bulletin board or telephone depth interview (TDI), interview regarding experiences and opinions as to condition and treatment
- Keywords
- patients or caregivers, for caregivers, loved one must still be living
- Medical subject headings
- Liver Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
bulletin board or telephone depth interview (TDI)Behavioural
experiential based research. anonymous participation.
interview regarding experiences and opinions as to condition and treatmentBehavioural
not a drug trial. experential/opinion based research.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Mar 2012 (estimated)
- Study startMar 2012
- Primary completionApr 2012 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Stage 4 Liver CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Time perspective
- Retrospective
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Find A Cure Panel
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Douglas Lowell, Find A Cure Panel
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01549522
- Sponsor's protocol ID
- facplc1001
- Status last verified
- Mar 2012
- First submitted
- 7 Mar 2012
- Last updated
- 9 Mar 2012
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Mar 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Phase 1 0 Qualitative Research for Stage 4 Liver Cancer Patients and Their Caregivers.
- ClinicalTrials.gov ID
- NCT01549522
- Acronym / sponsor ID
- facplc1001
- Conditions
- Stage 4 Liver Cancer
- Keywords
- patients or caregivers, for caregivers, loved one must still be living
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Find A Cure PanelUniversity, hospital or other
- Study start
- Mar 2012
- Primary completion
- Apr 2012 (estimated)
- First posted
- 9 Mar 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is opinion based, experiential research and is NOT a drug trial.
Study design
- Time perspective
- Retrospective
Who may qualify
- Ages
- 22 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- liver cancer stage 4 patients and caregivers
Key inclusion criteria (1 listed)
- stage 4 liver cancer patients and caregivers
Key exclusion criteria (1 listed)
- loved ones passed away
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| bulletin board or telephone depth interview (TDI)experiential based research. anonymous participation. | Behavioural | – |
| interview regarding experiences and opinions as to condition and treatmentnot a drug trial. experential/opinion based research. | Behavioural | – |
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Mar 2012.
- Related InfoLink provided by the sponsor.
Related trials for Stage 4 Liver Cancer
Not yet recruitingPhase 2
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Colorectal Cancer, Liver Metastases
Recruiting
CREO - Microwave Ablation Feasibility Study
Pancreatic Cancer, Liver Cancer (Locally Advanced or Metastatic)
Active, not recruiting
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
Bone Metastases, HER2-positive Breast Cancer
Active, not recruitingPhase 1/2
Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer
Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8
RecruitingPhase 1/2
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Stage 4 Liver Cancer, run by Find A Cure Panel at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 9 Mar 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact douglas lowell (323-717-8117, info@findacurepanel.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2012.